Cancer Treatments Have Advanced at the Fastest Pace in History; From FDA Approvals to an Incredible Decrease In Death Rates December 31, 2020By Shelby Black
Record Numbers of Cancer Drugs Approved- But Leading Experts Say Vital Clinical Trials Could Drop Off Hugely Due To COVID-19 May 29, 2020By Shelby Black
Two Major New Ovarian Cancer Approvals — Expanding Access To PARP Inhibitors May 11, 2020By Laura Gesualdi
After Recurrence: PARP Inhibitors Can Improve Ovarian Cancer Survival Rates May 1, 2020By Constance Costas
New Study Says Clinical Trials Don’t Have Enough Diversity, But Are Still Used To Determine Government Approvals For Cancer Drugs August 20, 2019By Zara Sternberg
Advanced Small Cell Lung Cancers Can Benefit from the Promising Immunotherapy Drug Keytruda Now, Too June 22, 2019By Caroline Hopkins
